Navigation Links
MolSoft's New Technology Brings Online Publications to Life in Fully Interactive 3D
Date:10/26/2009

SAN DIEGO, Oct. 26 /PRNewswire/ -- Scientific publishing is now going 3D. For the first time in online publishing history, the PLoS ONE journal is publishing original research papers containing fully annotated and interactive 3D objects. This 3D environment provides a "movie-like" experience but with a significant difference - the reader is in control of the scenes and each view is linked directly to the text. This is possible because of a new technology called ActiveICM developed by MolSoft LLC. ActiveICM is now being used for scientific publishing because of a collaboration with scientists at the Structural Genomics Consortium in the UK. Initially the technology is being applied to the life sciences for the 3D display of molecules implicated in diseases such as cancer and diabetes. ActiveICM can also be used for any online publication where a 3D view would enhance the subject matter.

ActiveICM allows the reader to visualize and explore 3D representations of any object. It is a guide, which brings you from view-to-view and location-to-location, but allows you to explore independently any region of the 3D object. Scientists involved in drug discovery were the first to utilize ActiveICM. Now pharmaceutical companies and academic research laboratories around the world are using this technology for their drug and structural data communication.

Professor Ruben Abagyan, MolSoft's Founder and Faculty member at the University of California, San Diego said, "This new technology enriches a scientific publication and allows the author of the paper to explain his or her results in a more visual and interactive way. The method developed at MolSoft will transform the way scientists communicate and exchange their data. ActiveICM gives the reader a sense of context, which is missing in all other animated media such as online movies. This truly is a step forward for scientific publishing, and we expect other branches of science and other industries to take the technology on board. "

See http://www.molsoft.com/plosone.html for more information and a link to the PLoS ONE collection.

About MolSoft

MolSoft is a San Diego, California-based company that is a primary source of new breakthrough technologies in molecular graphics, visualization, molecular modeling, docking, virtual screening and cheminformatics. Molsoft offers complete solutions for biotechnology or pharmaceutical researchers in the areas of computational biology and chemistry.

www.molsoft.com

SOURCE MolSoft


'/>"/>
SOURCE MolSoft
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
9. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
10. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
11. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)... India , January 18, 2017 According to a ... and by Application: Global Opportunity Analysis and Industry Forecast, 2014 - 2022," the ... to reach $1,127 million by 2022, growing at a CAGR of 8.26% from ... in terms of revenue. Continue Reading ... ...
(Date:1/18/2017)...  With an annual growth ranging from 6% to 10%, South East ... International Expo, March 22-24, 2017) serves the industry by fostering the regional discourse - ... Investment Forum ASEAN -- India ... conference content Enhanced business matchmaking program Roadshows ... ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment ... they have achieved certification to ISO 13485. This certification is another way they are ... date products and services that they need. , The ISO 13485 Certification is a ...
(Date:1/18/2017)... ... January 18, 2017 , ... Rollerblade®, the worldwide ... (ABT), an innovative braking system that allows skaters of all levels to stop ... the biggest concerns of beginner and intermediate skaters – learning how to brake ...
(Date:1/17/2017)... NY (PRWEB) , ... January 17, 2017 , ... Gym ... opening of a new showroom at South Dixie Hwy in Miami, FL. , “We ... at Gym Source. “The new innovative in-store concept is designed to give clients a ...
(Date:1/17/2017)... , ... January 17, 2017 , ... SunView Software’s Service ... for Innovation of the Year. , Each year, Pink Elephant recognizes a ... innovative approach to address a specific business problem or opportunity. The award highlights original ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Mirror Mirror ... earned the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, ... part of this elite group of providers. , Produced by Zeltiq, CoolSculpting is ...
Breaking Medicine News(10 mins):